Last checked at 12 Feb 2018 09:30
12 February 2018
Deltex Medical Group plc
("Deltex Medical", "Deltex" or "the Company")
Director dealing and issue of equity
Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring ("ODM") announces that it has issued 800,000 new Ordinary Shares of 1 pence each in the capital of the Company ("Ordinary Shares") in connection with the exercise of options by Ewan Phillips, Chief Executive Officer, granted under the Company's Enterprise Management Incentive Share Option Scheme. The options had an exercise price of 1 pence per share and the notice of exercise was received on 9 February 2018.
Application has been made for the 800,000 new Ordinary Shares to be admitted to trading on AIM ("Admission"), and dealings are expected to commence on 15 February 2018. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.
Following Admission, the total number of Ordinary Shares in issue with voting rights will be 490,663,367 Ordinary Shares. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Confirmation of Director's shareholding
Following the above purchase, Ewan Phillips owns 4,682,111 ordinary shares representing 0.95% per cent. of the Company's issued share capital.
For further information, please contact:-
Deltex Medical Group plc | 01243 774 837 investorinfo@deltexmedical.com |
Nigel Keen, Chairman | |
Ewan Phillips, Chief Executive | |
Jonathan Shaw, Group Finance Director | |
Nominated Adviser & Broker | |
Arden Partners plc | 020 7614 5900
|
Chris Hardie Ciaran Walsh | |
Joint Broker | |
Turner Pope Investments (TPI) Ltd | 0203 621 4120 info@turnerpope.com |
Andy Thacker | |
Financial Public Relations | |
IFC Advisory Ltd | 0203 053 8671
|
Tim Metcalfe Graham Herring Heather Armstrong |
PDMR Notification Forms:
The notifications below are made in accordance with the requirements of MAR.
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Ewan Phillips | ||||
2. | Reason for the Notification | |||||
a) | Position/status | Chief Executive | ||||
b) | Initial notification/amendment | Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Deltex Medical Group plc | ||||
b) | LEI | N/A | ||||
4. | Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted | |||||
a) | Description of the Financial instrument, type of instrument | Ordinary shares of 1 pence each | ||||
Identification code | GB00B95L0551 | |||||
b) | Nature of the Transaction | Exercise of share options | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | N/A (Single transaction) | ||||
e) | Date of the transaction | 15 February 2018 | ||||
f) | Place of the transaction | London Stock Exchange, AIM | ||||